Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-31 Sale | 2023-01-31 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 11,890 | $1.8696 | $22,230 | 19,535 (Direct) | View |
| 2022-08-01 Sale | 2022-08-01 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 21,040 | $1.7735 | $37,314 | 34,824 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Option Award | 2024-03-18 5:00 pm | N/A 2034-03-18 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 6,219,696 | $0 | 6,219,696 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-05 5:00 pm | N/A 2033-07-03 | Allovir Inc. | ALVR | Piccina Cintia Chief Commercial Officer | 420,000 | $0 | 420,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:02 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 1,902,888 | $0 | 1,902,888 (Direct) | View |
| 2022-01-31 Option Award | 2022-01-31 9:05 pm | N/A 2032-01-31 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 4,466,376 | $0 | 4,466,376 (Direct) | View |